Natalija Pavlović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natalija Pavlović has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ljiljana V. Marina
Center for Infertility and Endocrinology of Gender, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Milena Eric Jovičić
Institute of Virology, Vaccines and Sera “Torlak”, 11000 Belgrade, Serbia
1 shared publication - Milina Tancic-Gajic
Faculty of Medicine, University of Belgrade, Dr Subotića 8, 11000 Belgrade, Serbia
1 shared publication - Miomira Ivovic
Faculty of Medicine, National Center for Infertility and Endocrinology of Gender, Clinic of Endocrinology, Diabetes and Diseases of Metabolism, University Clinical Center, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Svetlana Jovicic-Pavlovic
Faculty of Medicine, University of Belgrade, Dr Subotića 8, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 1 April 2023
- Published by MDPI AG in Endocrines
- Vol. 4 (2) , 250-256
Alzheimer’s Disease and Premature Ovarian Insufficiency
Estradiol promotes neuronal growth, transmission, survival, myelinization, plasticity, synaptogenesis, and dendritic branching and it improves cognitive function. Alzheimer’s disease (AD) is characterized by amyloid plaques, neurofibrillary tangles, and the loss of neuronal connection in the brain. Genomic analysis has concluded that hypoestrogenism influences the APOE gene and increases the risk of AD. Premature ovarian insufficiency (POI) is defined as oligo/amenorrhea in women below 40 years of age, low estradiol, and high-gonadotropin levels. Early symptoms and signs of POI must be detected in time in order to prevent subsequent complications, such as Alzheimer’s disease. Meta-analysis has shown favorable effects of estrogen in preventing Alzheimer’s. We measured some of the typical markers of AD in women with POI such as interleukin 6 (IL-6), interleukin 8 (IL-8), tissue necrosis factor α (TNFα), TAU1, TREM2, and amyloid precursor proteins (APP). While FSH, LH, and IL-8 were significantly higher in POI group, compared to controls, testosterone and DHEAS were lower. A significant decrease in IL-6 was found in the POI group during a 6-month therapy, as well as an increase in amyloid precursor proteins. CONCLUSION: Neurological complications of POI, such as declining short-term memory, cognitive function, and dementia, have to be promptly stopped by initiating estro-progestogen therapy in POI. A long-term continuation of the therapy would be strongly advised.
- 1 April 2023
- Published by MDPI AG in Endocrines
- Vol. 4 (2) , 250-256
Open AccessAlzheimer’s Disease and Premature Ovarian Insufficiency
Estradiol promotes neuronal growth, transmission, survival, myelinization, plasticity, synaptogenesis, and dendritic branching and it improves cognitive function. Alzheimer’s disease (AD) is characterized by amyloid plaques, neurofibrillary tangles, and the loss of neuronal connection in the brain. Genomic analysis has concluded that hypoestrogenism influences the APOE gene and increases the risk of AD. Premature ovarian insufficiency (POI) is defined as oligo/amenorrhea in women below 40 years of age, low estradiol, and high-gonadotropin levels. Early symptoms and signs of POI must be detected in time in order to prevent subsequent complications, such as Alzheimer’s disease. Meta-analysis has shown favorable effects of estrogen in preventing Alzheimer’s. We measured some of the typical markers of AD in women with POI such as interleukin 6 (IL-6), interleukin 8 (IL-8), tissue necrosis factor α (TNFα), TAU1, TREM2, and amyloid precursor proteins (APP). While FSH, LH, and IL-8 were significantly higher in POI group, compared to controls, testosterone and DHEAS were lower. A significant decrease in IL-6 was found in the POI group during a 6-month therapy, as well as an increase in amyloid precursor proteins. CONCLUSION: Neurological complications of POI, such as declining short-term memory, cognitive function, and dementia, have to be promptly stopped by initiating estro-progestogen therapy in POI. A long-term continuation of the therapy would be strongly advised.